AI companies run virtual drug trials to boost success rates of human studies
HealthcareLdr · x · 2026-10-11
According to CNBS, AI companies are running 'virtual drug trials' — using AI to simulate drug effects before human studies begin, with the goal of improving the success rate of real clinical trials. The approach, part of AI's growing role in drug discovery and pharma, uses computational simulation to weed out weak candidates early and cut costly late-stage failures.
More from Research
- Laude Institute launches FrontierCS 2: agents must beat deleted paper contributions blind — lateinteraction · 2026-10-23
- OPAL: an LLM agent rewrites the optimizer's source code during training — RobertTLange · 2026-10-23
- RFD4-Proteina's 'underrated' docs detail partial diffusion for protein redesign — AllThingsApx · 2026-10-23
- MPI-Sec PhD Thesis on Vulnerability Detection Benchmarks Includes Pre-LLM Classic "Top Score on the Wrong Exam" — mboehme_ · 2026-10-23
- LiveNerf's 29-day data finds no nerfing of Claude Opus 5.5 — TheOnlyVibemaster · 2026-10-23
- New paper makes 9 falsifiable predictions toward a major AI-enabled terror attack by 2027-2028 — StephenLCasper · 2026-10-23